Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 2

Conditions

Lymphoma 201Leukemia 159Leukemia, Myeloid, Acute 134Precursor Cell Lymphoblastic Leukemia-Lymphoma 132Lymphoma, Non-Hodgkin 112Multiple Myeloma 111Lymphoma, Large B-Cell, Diffuse 108Lymphoma, Follicular 93Hodgkin Disease 92Burkitt Lymphoma 91Myelodysplastic Syndromes 87Lymphoma, Mantle-Cell 87Breast Neoplasms 85Leukemia, Lymphocytic, Chronic, B-Cell 84Lymphoma, Large-Cell, Immunoblastic 73Lymphoma, B-Cell, Marginal Zone 59Sarcoma 54Neoplasms, Plasma Cell 50Neuroblastoma 49Central Nervous System Neoplasms 46Leukemia, Myeloid, Chronic-Phase 43Recurrence 40Ovarian Neoplasms 39Leukemia, Myeloid, Accelerated Phase 39Congenital Abnormalities 39Myeloproliferative Disorders 38Dendritic Cell Sarcoma, Interdigitating 38Blast Crisis 34Leukemia, Myelomonocytic, Chronic 32Neutropenia 29

Interventions

Irinotecan 6Cyclophosphamide 5Carboplatin 3temsirolimus 2Sirolimus 2Filgrastim 2Early Intervention, Educational 2sargramostim 1reolysin 1irofulven 1etoposide phosphate 1cixutumumab 1aflibercept 1Vincristine 1Trabectedin 1Topotecan 1Tirapazamine 1Thiotepa 1Thalidomide 1Temozolomide 1Peripheral Blood Stem Cell Transplantation 1Pemetrexed 1Oxaliplatin 1Methylprednisolone 1Melphalan 1Mass Spectrometry 1Immunologic Techniques 1Immunohistochemistry 1Genetic Testing 1Gene Expression Profiling 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unspecified Childhood Solid Tumor, Protocol Specific × Filgrastim × Clear all
NCT00003194 2019-04-05

Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Solid Tumors

Seattle Children's Hospital

Phase 1 Terminated
24 enrolled
Other solid neoplasm

Unspecified Childhood Solid Tumor, Protocol Specific

NCT00003288 2013-02-05

Tirapazamine Plus Cyclophosphamide in Treating Children With Refractory Solid Tumors

National Cancer Institute (NCI)

Phase 1 Completed
12 enrolled
Other solid neoplasm

Unspecified Childhood Solid Tumor, Protocol Specific

Data powered by HemOnc (CC BY 4.0) Colophon âš¡